Oramed Pharm's total assets for Q3 2024 were $165.08M, a decrease of -10.39% from the previous quarter. ORMP total liabilities were $9.56M for the fiscal quarter, a 18.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.